We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!

MSFT 409.6999 -1.5286% AAPL 222.71 -1.8034% NVDA 128.3057 2.7103% GOOGL 163.14 -2.3465% GOOG 164.6592 -2.3142% AMZN 180.47 -3.2384% META 585.16 -1.8089% AVGO 175.79 -0.4812% TSLA 241.6955 -3.3527% TSM 183.57 1.3303% LLY 899.35 1.374% V 273.29 -1.6695% JPM 209.74 -0.7007% UNH 584.575 -1.1206% NVO 117.48 2.05% WMT 79.45 -1.8409% LVMUY 148.82 1.4451% XOM 125.47 0.5127% LVMHF 745.0 1.5609% MA 491.24 -1.298%

Vicapsys Life Sciences Inc

Healthcare US VICP

7.0USD
-(-%)

Last update at 2024-10-04T13:30:00Z

Day Range

7.007.00
LowHigh

52 Week Range

1.003.00
LowHigh

Fundamentals

  • Previous Close 7.00
  • Market Cap87.88M
  • Volume0
  • P/E Ratio-
  • Dividend Yield9.60%
  • EBITDA-0.64086M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.03

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -0.98479M -0.76584M -0.76584M -1.03391M -2.20211M
Minority interest - - - - -
Net income -1.66525M -0.76584M -0.76584M -1.40970M -2.20211M
Selling general administrative 0.63M 0.66M 0.66M 0.93M 2.48M
Selling and marketing expenses - - - - -
Gross profit - - - - 0.74M
Reconciled depreciation 0.03M 0.03M 0.03M 0.03M -
Ebit -0.98479M -0.76584M -0.76584M -1.03391M -1.28458M
Ebitda -0.27304M -0.73442M -0.73442M -1.00261M -
Depreciation and amortization 0.71M 0.03M - 0.03M -
Non operating income net other - - - - -
Operating income -0.98479M -0.76584M -0.76584M -1.03391M -2.20211M
Other operating expenses 0.64M 0.77M - 1.03M -
Interest expense 0.68M 0.10M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M - 0.00000M 0.00000M -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.68M -0.10000M - 0.38M -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.74M
Total operating expenses 0.64M 0.77M 0.77M 1.03M 2.94M
Cost of revenue - - - - -
Total other income expense net -0.34023M 0.10M - - -
Discontinued operations - - - -0.37579M -0.91753M
Net income from continuing ops -0.98479M -0.23687M -0.76584M -1.03391M -2.20211M
Net income applicable to common shares -0.98834M -0.23687M -0.76584M -1.57018M -2.20211M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.07M 0.40M 0.40M 0.70M 0.80M
Intangible assets - 0.40M 0.40M 0.43M 0.47M
Earning assets - - - - -
Other current assets 0.06M 0.00550M - - -
Total liab 1.02M 0.85M 0.85M 0.40M 1.05M
Total stockholder equity -0.95079M -0.44911M -0.44911M 0.30M -0.26111M
Deferred long term liab - - - - -
Other current liab 0.12M 0.12M - - 0.70M
Common stock 0.03M 0.02M 0.02M 0.02M 0.00965M
Capital stock 0.03M 0.02M 0.02M 0.02M -
Retained earnings -15.11796M -13.89275M -13.89275M -13.12691M -11.55673M
Other liab - - - - -
Good will - - - - -
Other assets - - - - 0.24M
Cash 0.01M 0.00127M 0.00127M 0.26M 0.09M
Cash and equivalents - - - - -
Total current liabilities 1.02M 0.85M 0.85M 0.40M 1.05M
Current deferred revenue - - - - -
Net debt -0.01410M -0.00127M - -0.26417M -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 15.09M 13.42M 0.00065M 13.40M 0.00361M
Property plant equipment - - - - 0.21M
Total current assets 0.07M 0.00127M 0.00127M 0.26M 0.09M
Long term investments - - - - -
Net tangible assets -0.95079M -0.49317M -0.85940M -0.13976M -0.72669M
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.91M 0.74M 0.51M 0.40M 0.35M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.40M 0.40M 0.43M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M 0.10M 0.10M 0.10M 0.10M
Change to liabilities 0.27M -0.13726M 0.34M 0.05M -0.08396M
Total cashflows from investing activities - 0.10M 0.10M 0.10M -0.03802M
Net borrowings - - - - 0.18M
Total cash from financing activities 0.03M 0.56M 0.56M 1.15M 1.67M
Change to operating activities -0.00198M -0.00550M 0.12M 0.12M 0.02M
Net income -0.98479M -0.76584M -0.76584M -1.03391M -2.20211M
Change in cash -0.20320M -0.26290M -0.26290M 0.18M -0.46127M
Begin period cash flow 0.22M 0.26M 0.26M 0.09M -
End period cash flow 0.01M 0.00127M 0.00127M 0.26M 0.09M
Total cash from operating activities -0.23820M -0.26290M -0.26290M -0.97026M -2.08867M
Issuance of capital stock 0.00000M 0.56M 0.00000M 0.97M -
Depreciation 0.03M 0.03M 0.03M 0.03M 0.13M
Other cashflows from investing activities - - - - -0.03802M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.03M 0.10M -0.01500M 0.18M 0.18M
Change to netincome 0.45M -0.09567M 0.01M 0.36M 0.06M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.27M 0.46M 0.46M 0.05M -
Stock based compensation 0.11M 0.01M 0.01M 0.12M -
Other non cash items 0.34M -0.10000M - -0.13283M -
Free cash flow -0.23820M -0.26290M -0.26290M -0.97026M -

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VICP
Vicapsys Life Sciences Inc
- -% 7.00 - - 0.004 0.03 0.84 -122.1975
NVO
Novo Nordisk A/S
2.36 2.05% 117.48 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S
3.56 3.12% 117.60 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc
-5.645 1.24% 449.67 29.67 24.33 10.38 5.83 9.33 20.00
REGN
Regeneron Pharmaceuticals Inc
-15.105 1.49% 997.72 29.07 20.12 7.57 3.82 6.95 19.42

Reports Covered

Stock Research & News

Profile

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Cumming, Georgia.

Vicapsys Life Sciences Inc

7778 Mcginnis Ferry Road, Suwanee, GA, United States, 30024

Key Executives

Name Title Year Born
Mr. Federico Pier CEO, Exec. Chairman & Interim Pres 1968
Mr. Jeffery Wright CPA, CPA Chief Financial Officer 1983
Dr. Mark C. Poznansky M.D., Ph.D. Chief Scientist Advisor & Founder NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.